Staley Capital Advisers Inc. Purchases 7,665 Shares of Corteva, Inc. $CTVA

Staley Capital Advisers Inc. increased its position in Corteva, Inc. (NYSE:CTVA) by 1.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 543,743 shares of the company’s stock after buying an additional 7,665 shares during the quarter. Corteva accounts for 1.5% of Staley Capital Advisers Inc.’s portfolio, making the stock its 20th largest position. Staley Capital Advisers Inc. owned about 0.08% of Corteva worth $36,447,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of CTVA. Northwestern Mutual Wealth Management Co. lifted its position in Corteva by 6,527.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after purchasing an additional 3,100,709 shares during the last quarter. Perpetual Ltd raised its holdings in shares of Corteva by 78,688.5% during the fourth quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after acquiring an additional 2,612,459 shares in the last quarter. Amundi raised its holdings in shares of Corteva by 125.3% during the third quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after acquiring an additional 1,899,248 shares in the last quarter. Squarepoint Ops LLC raised its holdings in shares of Corteva by 423.6% during the third quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock valued at $117,550,000 after acquiring an additional 1,406,199 shares in the last quarter. Finally, Man Group plc raised its holdings in shares of Corteva by 16,474.3% during the third quarter. Man Group plc now owns 1,294,125 shares of the company’s stock valued at $87,522,000 after acquiring an additional 1,286,317 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Down 1.4%

NYSE CTVA opened at $82.17 on Friday. The stock’s 50-day moving average price is $81.11 and its 200-day moving average price is $73.37. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The company has a market capitalization of $54.95 billion, a P/E ratio of 48.33, a price-to-earnings-growth ratio of 2.52 and a beta of 0.59.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter last year, the company earned $1.13 earnings per share. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts predict that Corteva, Inc. will post 3.7 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be given a dividend of $0.18 per share. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.15% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently weighed in on CTVA. JPMorgan Chase & Co. cut Corteva from an “overweight” rating to a “neutral” rating and upped their price target for the stock from $75.00 to $77.00 in a research note on Thursday, February 5th. UBS Group increased their price objective on Corteva from $88.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Weiss Ratings raised Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. Royal Bank Of Canada increased their target price on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Finally, Citigroup increased their target price on Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Thirteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $88.14.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.